Matches in Nanopublications for { ?s ?p "[Interestingly, combined inhibition of IL-17A and IL-22 did not worsen abscesses but did increase gamma interferon (IFN-?) expression at these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Interestingly, combined inhibition of IL-17A and IL-22 did not worsen abscesses but did increase gamma interferon (IFN-?) expression at these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Interestingly, combined inhibition of IL-17A and IL-22 did not worsen abscesses but did increase gamma interferon (IFN-?) expression at these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1293865.RAWYLXYqSg-JYDxJ_Vb3o0pxR3lY3RDYov4FDiklVO-Vo130_assertion description "[Interestingly, combined inhibition of IL-17A and IL-22 did not worsen abscesses but did increase gamma interferon (IFN-?) expression at these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293865.RAWYLXYqSg-JYDxJ_Vb3o0pxR3lY3RDYov4FDiklVO-Vo130_provenance.
- NP1293867.RAm2TDAeG3RHBK9atSCyOso_NZMDI-h1x3QMWj2lPGWX4130_assertion description "[Interestingly, combined inhibition of IL-17A and IL-22 did not worsen abscesses but did increase gamma interferon (IFN-?) expression at these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293867.RAm2TDAeG3RHBK9atSCyOso_NZMDI-h1x3QMWj2lPGWX4130_provenance.
- NP1293866.RA21lYjbWqZ1P42kRY_UP2viuDDUV7fslqT96rzDW_T-0130_assertion description "[Interestingly, combined inhibition of IL-17A and IL-22 did not worsen abscesses but did increase gamma interferon (IFN-?) expression at these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293866.RA21lYjbWqZ1P42kRY_UP2viuDDUV7fslqT96rzDW_T-0130_provenance.